Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Ascites predicts treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube and peritoneal cancers: An NRG Oncology/GOG study

James Stuart Ferriss,J Java,Michael A Bookman,Gini F Fleming,Bradley J Monk,Joan L Walker,Howard D Homesley,Jeffrey M Fowler,Benjamin E Greer,Matthew Boente,Robert A Burger

Gynecologic Oncology（2015）

Cited 77|Views21
No score
Abstract
•We analyzed data from GOG 0218 to determine if ascites predicts response to bevacizumab.•Ascites was shown to be a negative prognostic factor in epithelial ovarian cancers.•Ascites is a significant clinical factor that may predict response to bevacizumab.
More
Translated text
Key words
Bevacizumab,Advanced epithelial ovarian cancer,Front-line therapy,NRG Oncology,GOG
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined